Silo Pharma (SILO) shares were down 10% in recent premarket activity on Thursday, a day after the company began trading on Nasdaq on a split-adjusted basis.
The company said earlier this week that it has completed a 1-for-15 reverse stock split of its issued, outstanding, and authorized common shares, effective June 2.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments